Kirk Agerson
Family Medicine · Grand Rapids, MINPI 1245226380
Payments from drug & device makers
Across 60 payments — averaging $16.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$131
- Pfizer$121
- Johnson & Johnson$70
- Novartis$68
- Novo Nordisk$64
- Boehringer Ingelheim$60
- plus $457 from 16 others
What the payments were for
- Food & beverage$972100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 8 | $131 |
| Pfizer | 8 | $121 |
| Johnson & Johnson | 4 | $70 |
| Novartis | 4 | $68 |
| Novo Nordisk | 4 | $64 |
| Boehringer Ingelheim | 3 | $60 |
| AbbVie(2 entities) | 4 | $60 |
| Dexcom, Inc. | 3 | $58 |
| Merck | 3 | $52 |
| GSK | 4 | $50 |
| Amarin Pharma, Inc. | 2 | $35 |
| AstraZeneca | 2 | $30 |
| Bardy Diagnostics, Inc. | 2 | $27 |
| Eisai Inc. | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Ironshore Pharmaceuticals Inc. | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Boston Scientific | 1 | $15 |
| Amgen | 1 | $15 |
| Biogen | 1 | $11 |
| Teva Pharmaceuticals USA, Inc. | 1 | $11 |
How this compares
$972 in reported general payments places this provider in the 70th percentile of 3,945 family medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 31 | $36,566 |
| MyrbetriqMirabegron | 19 | $12,913 |
| Rosuvastatin Calcium | 86 | $2,830 |
| Atorvastatin Calcium | 94 | $1,865 |
| Dutasteride | 18 | $1,754 |
| Levothyroxine Sodium | 88 | $1,648 |
| Colchicine | 11 | $1,138 |
| Tamsulosin Hcl | 37 | $1,058 |
| Metformin Hcl | 45 | $812 |
| Potassium Chloride | 19 | $796 |
| Celecoxib | 12 | $786 |
| Omeprazole | 41 | $685 |
| Ezetimibe | 21 | $667 |
| Famotidine | 20 | $636 |
| Lisinopril | 47 | $576 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $121 | $36,56631 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,945 family medicine providers in Michigan.
Other family medicine in Grand Rapids
- Rhonda MejeurGrand Rapids$493K
- Mary DagenGrand Rapids$265K
- Nirali BoraGrand Rapids$133K
- Oren MasonGrand Rapids$97K
- Magalis LlovetGrand Rapids$21K
- Derrick WilliamsonSouthfield$9.9M
- Rebecca RivardRoseville$7M
- Paul BensonBerkley$4.2M
- Michael HafranEast Lansing$2.7M
- Mitzie HewittBuckley$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.